Discover Top Posts Tagged with #nasdaq:nbix

Neurocrine Biosciences (NBIX) – Research Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Neurocrine Biosciences (NASDAQ: NBIX): 12/8/2021 – Neurocrine Biosciences had its price target raised by analysts at Oppenheimer Holdings Inc. from $140.00 to $154.00. They now have an “outperform” rating on the stock. 12/8/2021 – Neurocrine Biosciences was upgraded by analysts at Zacks Investment Research from a “sell”…

View On WordPress

#NASDAQ:NBIX #NBIX #Neurocrine Biosciences Inc

Analyst Activity – Leerink Swann Reiterates Outperform on Neurocrine Biosciences (NASDAQ:NBIX)

Analyst Ratings For Neurocrine Biosciences (NASDAQ:NBIX) Today, Leerink Swann reiterated its Outperform rating on Neurocrine Biosciences (NASDAQ:NBIX) with a price target of $70.00. There are 1 sell rating, 2 hold ratings, 10 buy ratings on the stock. The current consensus rating on Neurocrine Biosciences (NASDAQ:NBIX) is Buy (Score: 2.69) with a consensus target price of $66.92 per share, a…

View On WordPress

#8-K #NASDAQ:NBIX #NBIX #Neurocrine Biosciences #SEC Filings

Analyst Activity – Leerink Swann Reiterates Outperform on Neurocrine Biosciences (NASDAQ:NBIX)

Analyst Ratings For Neurocrine Biosciences (NASDAQ:NBIX) Today, Leerink Swann reiterated its Outperform rating on Neurocrine Biosciences (NASDAQ:NBIX) with a price target of $70.00. There are 1 sell rating, 2 hold ratings, 10 buy ratings on the stock. The current consensus rating on Neurocrine Biosciences (NASDAQ:NBIX) is Buy (Score: 2.69) with a consensus target price of $66.92 per share, a…

View On WordPress

#8-K #NASDAQ:NBIX #NBIX #Neurocrine Biosciences #SEC Filings

#nasdaq:nbix

Trending Tags

Recently Viewed Tags

#nasdaq:nbix